USANA Health Sciences, Inc. (FRA:USJ)

Market Cap	336.25M -41.6%
Revenue (ttm)	787.76M +8.3%
Net Income	9.16M -74.4%
EPS	0.49 -73.5%
Shares Out	n/a
PE Ratio	36.70
Forward PE	10.83
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	6
Open	17.20
Previous Close	16.90
Day's Range	17.20 - 17.90
52-Week Range	15.70 - 32.00
Beta	n/a
RSI	55.35
Earnings Date	Feb 17, 2026

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Direct selling and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal...

• Industry: Pharmaceutical Preparations
• Founded: 1992
• Employees: 1,700
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: USJ

Financial Performance

In fiscal year 2025, USANA Health Sciences's revenue was $925.26 million, an increase of 8.28% compared to the previous year's $854.50 million. Earnings were $10.76 million, a decrease of -74.40%.

Financial numbers in USD